Swine it #127: Dr Locke Karriker: The balance between animal welfare and the use of antibiotics


February 23, 2022

clock icon
2 minute read

The use of antibiotics has become a major area of ​​interest for the swine industry over the past decades. With more and more resistance genes emerging, we need to do our best to limit the use of antibiotics so that we can continue to use them for as long as possible. In today’s interview with Dr. Karriker, he talks about the appropriate use of antibiotics in the swine industry and how we can maximize health while reducing antibiotic use on our farms. pigs.

Listen on Spotify

Listen on Apple Podcasts

What you will learn:

1. The Swine Medicine Education Center

2. Use of antibiotics in the swine industry

3. Antibiotic resistance

4. Potential introduction of new resistance genes

5. What policy makers should do

6. Balancing animal welfare and antibiotic use

7. Antibiotic management

8. Parameters to measure antibiotic use

9. Rules

10. What’s in the future

Meet the guest: Dr. Locke Karriker is a professor in the Department of Veterinary Diagnostics and Production Animal Medicine (VDPAM) at the College of Veterinary Medicine at Iowa State University. His position involves a mix of teaching, research, and professional practice that all focus on the improvement and advancement of swine medicine and the judicious use of antimicrobial therapy. This includes serving as Director of the Swine Medicine Education Center (SMEC) since 2003. Dr. Karriker is an active member of national committees committed to the judicious use of antimicrobials, including the Pharmaceutical Issues Committee of the American Association of Swine Veterinarians and the Public Occupational Health and Safety Committee of the National Pork Board. Dr. Karriker is one of the editors of the essential reference book on swine medicine, Diseases of Swine (10th and 11th editions), and is the lead author of the chapter “Drug Pharmacology, Therapy, and Prophylaxis”. His research activities focus on the diagnosis and treatment of swine diseases. He is particularly dedicated to advancing knowledge of pharmacology and welfare, better characterizing pathological conditions, and evaluating new intervention strategies for the swine industry.


Comments are closed.